Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023

December 18, 2023

https://www.prnewswire.com/news-releases/lilly-extends-tender-offer-to-acquire-point-biopharma-to-dec-22-2023-302017457.html

INDIANAPOLIS, Dec. 18, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares (“Shares”) of common stock of POINT Biopharma Global Inc. (NASDAQ: PNT), for a purchase price of $12.50 per share in cash, without interest and less any applicable tax withholding.

Read more at prnewswire.com

Related news for (PNT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.